---
document_datetime: 2023-09-21 21:55:57
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/xenpozyme-epar-all-authorised-presentations_en.pdf
document_name: xenpozyme-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0656842
conversion_datetime: 2025-12-22 12:03:39.929183
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

| EU/1/22/1659/001   | Xenpozyme   | 20 mg   | Powder for concentrate for solution for infusion   | Intravenous use   | Vial (glass)   | 1 Vial   |
|--------------------|-------------|---------|----------------------------------------------------|-------------------|----------------|----------|
| EU/1/22/1659/002   | Xenpozyme   | 20 mg   | Powder for concentrate for solution for infusion   | Intravenous use   | Vial (glass)   | 5 Vials  |
| EU/1/22/1659/003   | Xenpozyme   | 20 mg   | Powder for concentrate for solution for infusion   | Intravenous use   | Vial (glass)   | 10 Vials |
| EU/1/22/1659/004   | Xenpozyme   | 20 mg   | Powder for concentrate for solution for infusion   | Intravenous use   | Vial (glass)   | 25 Vials |
| EU/1/22/1659/005   | Xenpozyme   | 4 mg    | Powder for concentrate for solution for infusion   | Intravenous use   | Vial (glass)   | 1 Vial   |
| EU/1/22/1659/006   | Xenpozyme   | 4 mg    | Powder for concentrate for solution for infusion   | Intravenous use   | Vial (glass)   | 5 Vials  |
| EU/1/22/1659/007   | Xenpozyme   | 4 mg    | Powder for concentrate for solution for infusion   | Intravenous use   | Vial (glass)   | 10 Vials |